BELLUS Health Inc. (BLU): Price and Financial Metrics
BLU Price/Volume Stats
| Current price | $14.74 | 52-week high | $14.76 |
| Prev. close | $14.74 | 52-week low | $6.38 |
| Day low | $14.74 | Volume | 3,449,200 |
| Day high | $14.75 | Avg. volume | 3,081,445 |
| 50-day MA | $14.55 | Dividend yield | N/A |
| 200-day MA | $10.13 | Market Cap | 1.87B |
BLU Stock Price Chart Interactive Chart >
BELLUS Health Inc. (BLU) Company Bio
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. BELLUS Health Inc. was founded in 1993 and is headquartered in Laval, Canada.
BLU Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 139.67% |
| 5-year | 108.49% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | 2.11% |
| 2021 | 163.07% |
| 2020 | -59.74% |
| 2019 | 175.96% |
Loading social stream, please wait...